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Objective
The objective of this study was to describe the performance of the
measles surveillance in Lagos, characterize the epidemiologic pat-
tern of measles infection and determine the measles vaccine efficacy.
Introduction
Measles is a vaccine preventable disease that has been success-
fully eliminated in some parts of the world. It causes high morbidity
and mortality with the potential of large outbreaks. About a third of
reported measles cases involve one or more complications including
diarrhea, pneumonia, otitis media, blindness, post infections en-
cephalitis and subacute sclerosing panencephalitis. It is however, one
of the leading causes of childhood morbidity and mortality in Nige-
ria despite availability of safe and effective vaccines
Methods
We obtained the measles surveillance data for all the 20 Local
Governments Areas (LGAs) in Lagos and reviewed all the measles
case based investigation forms between the period 1st January to 31st
December 2010.The WHO Recommended Surveillance Standards
for Measles was used. Data was analyzed using EPI INFO version
3.5.3.
Results
Of the 615 suspected measles cases, 63(10.2%) were laboratory
confirmed (measles IGM+) and 3(0.5%) clinically confirmed. Cases
investigated within 48 hours was 222 (36%) (target ! 80%), 510
(83%) had adequate blood sample collected (target ! 80%) and 595
(97%) of sample results were received from the lab within 7 days
(target ! 80%). The surveillance system sensitivity was 6.5/100,000
(target >2/100,000) with a predictive value positive of 10.73%. The
overall attack rate was 0.73/100,000 population with 1 mortality (case
fatality rate 1.5%). The Under 1 year attack rate (8.33/100,000) was
higher than the 1- 4 years attack rate (3.48/100,000) (p= 0.01). Those
vaccinated with at least 1 dose of measles vaccine had a 3 times lower
risk of measles infection than the unvaccinated. The proportion of
unvaccinated cases was 36%. The measles vaccine efficacy was 60%.
Conclusions
The quality of surveillance need to be strengthened by improving
the time lapse between notification and investigation of suspected
cases. Measles is still a significant cause of morbidity particularly
among the under 1 year age group.The proportion of unvaccinated
cases is also high, suggesting a low vaccine coverage among sus-
ceptibles.
Prompt investigation of cases, good vaccine coverage and high
vaccine efficacy are all vital in eliminating measles from Nigeria.
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